- Global Pharma News & Resources

Photocure ASA: Presentation of the second quarter and first half year 2018 results

Photocure will present its second quarter and first half year report on Wednesday 8 August 2018 at Hotel Continental, Oslo, Norway.

The presentation will begin at 08:30 (CET) and representatives from the company will be Erik Dahl, Interim CEO and CFO and Ambaw Bellete, President, Photocure Inc. and Head, US Cancer Commercial Operations. The presentation will be held in English.

The presentation will be publicly available at . It will be possible to follow the presentation through .

A light snack will be served from 08:00 (CET). The presentation is scheduled to conclude at 09:15 (CET).

As the presentation will be held in English, there will be no audio webcast and conference call in the afternoon.

Please register your attendance to the presentations at Photocure by Tuesday 7 August.
Contact person: Tolv Hillestad (e-mail: / phone +47 22 06 22 10).

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Photocure ASA via GlobeNewswire

Editor Details

Last Updated: 03-Aug-2018